- July 8, 2014 - TEMPE, Ariz. --
Clinical Research Advantage/Radiant Research (CRA/Radiant)
, the country’s largest wholly owned clinical trial site management organization, is excited to announce the addition of a new clinical research site in Mesquite, Texas. CRA/Radiant has partnered with Dr. Salma Mazhar, MD, to open the site, which is located at 901 N. Galloway Avenue, suite 107. Dr. Mazhar will serve as the site’s principal investigator.
CRA/Radiant is a clinical trial site management organization that teams up with local physicians to set up clinical research sites within established medical offices. By partnering with community practices, CRA/Radiant is able to facilitate the rapid recruitment of reliable and qualified trial participants. The partnerships also foster a higher level of study compliance, as CRA/Radiant’
s partner physicians give participants expert medical attention during the trial.
CRA/Radiant staffs each clinical research office with its highly trained clinical research coordinators, research assistants and other research professionals. The staff members work with the physician to conduct the clinical trial with patient safety as the top priority. This includes providing coordination and regulatory support, and a full execution of the protocol with complete and accurate data.
To learn more about studies taking place at this site and other CRA/Radiant sites, call 1-855-4-A-STUDY (1-855-427-8839)
or visit http://crastudies.com/content/p/upcomingstudies
.About Clinical Research Advantage/Radiant Research
Tempe, Ariz.-based Clinical Research Advantage/Radiant Research (CRA/Radiant)
is the country’s largest wholly owned clinical trial site management organization. CRA/Radiant works with pharmaceutical companies and contract research organizations to perform clinical trials for pharmaceuticals, vaccines and medical devices. The services provided by CRA/Radiant allow trial sponsors to bring medical advancements to market quickly and efficiently. Founded in 1992, CRA acquired Radiant Research in 2012 and Comprehensive Clinical Development in 2013. Combined, the companies have 82 locations and have successfully completed more than 12,000 clinical trials. For more information, visit www.crastudies.com